Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.
暂无分享,去创建一个
K. Bensalah | F. Montorsi | Y. Lotan | V. Margulis | C. Wood | C. Langner | M. Remzi | S. Shariat | P. Karakiewicz | J. Raman | A. Weizer | E. Kikuchi | M. Oya | T. Koppie | C. Bolenz | W. Kassouf | M. Roscigno | S. Mikami | N. Suardi | Mario I. Fernández
[1] U. Capitanio,et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. , 2008, European urology.
[2] K. Kihara,et al. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. , 2008, The Journal of urology.
[3] M. Brausi,et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. , 2007, European urology.
[4] L. Kavoussi,et al. Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. , 2007, European urology.
[5] W. Oosterlinck. Ureteral tumour: a specific upper urinary tract transitional cell carcinoma. , 2007, European urology.
[6] O. Cussenot,et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. , 2007, European urology.
[7] K. Ohba,et al. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. , 2006, The Journal of urology.
[8] E. Kikuchi,et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. , 2005, The Journal of urology.
[9] Yair Lotan,et al. Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy , 2005 .
[10] S. Groshen,et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. , 2005, The Journal of urology.
[11] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[12] K. Alitalo,et al. Lymphangiogenesis and Cancer , 2004, Cancer Research.
[13] R. Sylvester,et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. , 2004, European urology.
[14] Choung-Soo Kim,et al. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. , 2004, The Journal of urology.
[15] M. Kattan,et al. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy. , 2003, Cancer research.
[16] R. Fimmers,et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] L. Akslen,et al. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[19] L. Ellis,et al. Simplified staging for hepatocellular carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Pepper,et al. Lymphangiogenesis and tumor metastasis: myth or reality? , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] L. Ellison,et al. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. , 2000, The Journal of urology.
[22] Lawrence D. True,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .
[23] T. Carmody,et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. , 1998, Urology.
[24] F. Mostofi,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.
[25] S. Kubodera,et al. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. , 1997, The Journal of urology.
[26] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[27] S. Kitada,et al. The prognostic significance of vascular invasion in upper urinary tract transitional cell carcinoma. , 1992, The Journal of urology.
[28] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.